The Ehlers-Danlos syndromes (EDS) represent a genetically and clinically heterogeneous group of inherited connective tissue diseases (for a review see Malfait et al., 2020) that share clinical features including joint hypermobility, tissue fragility, and skin changes with a spectrum of severity that goes from subclinical to life-threatening. The 2017 international Ehlers-Danlos syndrome classification describes 13 different types of EDS and a fourteenth rare subtype has recently been identified (Blackburn et al., 2018;Malfait et al., 2017). Variants in 20 distinct genes can cause